Agilent Technologies (NYSE:A) Releases FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.900-6.040 for the period, compared to the consensus EPS estimate of 5.930. The company issued revenue guidance of $7.3 billion-$7.5 billion, compared to the consensus revenue estimate of $7.3 billion. Agilent Technologies also updated its Q2 2026 guidance to 1.390-1.420 EPS.

Agilent Technologies Trading Up 0.5%

Shares of Agilent Technologies stock traded up $0.62 during trading on Friday, hitting $121.59. The stock had a trading volume of 1,061,060 shares, compared to its average volume of 2,168,879. Agilent Technologies has a 1 year low of $96.43 and a 1 year high of $160.27. The stock has a 50 day simple moving average of $134.99 and a 200 day simple moving average of $135.87. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $34.39 billion, a PE ratio of 26.79, a P/E/G ratio of 3.62 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period in the prior year, the business posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts expect that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is currently 22.32%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on A shares. Morgan Stanley began coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating for the company. Wells Fargo & Company dropped their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday. Citigroup increased their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Barclays lowered their price objective on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.29.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Top-line growth and multi-year guide: Agilent reported ~7% YoY revenue growth and set FY26 revenue at $7.3B–$7.5B while outlining initiatives (Ignite operating system) aimed at margin expansion — supporting the company’s medium-term profitability story. Seeking Alpha: Ignite / FY26 guidance
• Neutral Sentiment: Guidance largely in line: Agilent’s Q2 EPS guide (1.390–1.420) and FY EPS guide (5.900–6.040) sit close to Street expectations, giving some stability to forward estimates even as near-term execution missed by a hair. (Company press release / slides)
• Negative Sentiment: Earnings and revenue misses pressured the stock: Q1 EPS came in at $1.36 vs. $1.37 consensus and revenue was ~$1.80B vs. ~$1.81B–$1.84B expected, prompting downside reaction. Investing.com: Q1 earnings miss
• Negative Sentiment: Weather and margin pressure: Management said a U.S. snowstorm hurt shipments and service in the quarter, contributing to margin softness and a noticeable decline in operating cash flow — factors investors flagged as near-term headwinds. MarketWatch: Winter storm impact
• Negative Sentiment: Analysts trimmed price targets: Several firms lowered targets (UBS, TD Cowen, Wells Fargo, Barclays) while largely keeping buy/overweight ratings — the cuts remove some near-term upside and likely amplified selling. TickerReport / Benzinga: analyst target cuts
• Negative Sentiment: Shares reacted despite mostly in-line fundamentals: Coverage notes the EPS miss was small but combined with margin/cash-flow weakness it was enough to push sentiment lower; several headlines summarized the miss and sell‑off. Zacks: Q1 miss / margin pressure

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors have recently bought and sold shares of the stock. Compound Planning Inc. boosted its stake in shares of Agilent Technologies by 47.8% during the 4th quarter. Compound Planning Inc. now owns 3,705 shares of the medical research company’s stock worth $504,000 after acquiring an additional 1,199 shares in the last quarter. Invesco Ltd. boosted its position in Agilent Technologies by 32.0% during the fourth quarter. Invesco Ltd. now owns 2,590,715 shares of the medical research company’s stock worth $352,519,000 after purchasing an additional 627,804 shares during the period. Corient Private Wealth LLC boosted its position in Agilent Technologies by 53.7% during the fourth quarter. Corient Private Wealth LLC now owns 284,303 shares of the medical research company’s stock worth $38,685,000 after purchasing an additional 99,385 shares during the period. Mercer Global Advisors Inc. ADV grew its holdings in Agilent Technologies by 1.9% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 60,542 shares of the medical research company’s stock valued at $8,238,000 after purchasing an additional 1,131 shares during the last quarter. Finally, Vident Advisory LLC raised its position in shares of Agilent Technologies by 4.7% in the fourth quarter. Vident Advisory LLC now owns 17,052 shares of the medical research company’s stock valued at $2,320,000 after purchasing an additional 765 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.